Statewide Program Speeds Up Heart Attack Care in North Carolina
A program designed to speed up heart attack care has led to significant improvement in the quality of care for heart attack patients after it was extended across North Carolina last year, according to researchers at Duke University Medical Center.
Nov. 16, 2010
Major Study Shows Ability of New Agent to Prevent Strokes in Patients with Atrial Fibrillation
In the primary result from the largest double-blind study ever completed to assess a drug’s effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting drug, was shown to be superior to warfarin, the current standard for treatment of atrial fibrillation, while patients in the study were taking study drug. However, the full intention-to-treat analysis, which includes patients who discontinued study drug, showed that rivaroxaban was non inferior to warfarin for the prevention of stroke or blood clots but did not demonstrate statistical superiority.
Nov. 15, 2010
World’s Largest Heart Failure Study Finally Answers Questions About Nesiritide
Results from the largest acute heart failure study ever conducted have resolved safety questions raised five years ago about the acute heart failure medication nesiritide (Natrecor), but more importantly illustrate the need for comprehensive, large, real world studies of investigational agents early in the course of development of new therapies, according to researchers at the Duke Clinical Research Institute.
Nov. 15, 2010
Transfusion Rates Vary Extremely in Cardiac Bypass Surgery
Transfusion rates for blood products used in a common heart surgery range from no patients to nearly all patients, and vary by hospital, according to findings from a group of researchers from Duke University Medical Center. The study, which looked at data from 102,470 patients in 798 hospitals, examined the variation in transfusion rates for red blood cells (RBCs), plasma and platelets, but the team didn't reach conclusions about how well patients fared if they did or didn't get a transfusion.
Oct. 12, 2010
End of Life Trends in Heart Failure Care in the U.S. and Canada
A new analysis of trends in end-of-life care for heart-failure patients reveals shifts in how care is provided, surprising use of diagnostic tests and procedures, and striking comparisons with Canada’s universal health care system, according to researchers at the Duke Clinical Research Institute.
Oct. 11, 2010